ArticleThoracic cancer2021

Predictors of survival among Japanese patients receiving first-line chemoimmunotherapy for advanced non-small cell lung cancer.

Yuri Ogura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.